Respiratory Disorders Market in United States, Forecast to 2022

Current Spending on Respiratory Care in the United States

Respiratory Care Spending by Care Continuum

Investment Landscape in Sleep and Respiratory Disease Sector by Clinical Applications

Focus of OEMs in Sleep and Respiratory Disorders

Spending on Sleep and Respiratory Disorders—Summary

Trends Shaping the Sleep and Respiratory Care Industry

Sleep and Respiratory Disease Burden in the United States

Spending on Sleep and Respiratory Disorders—Summary

Overview of Lung Cancer—Disease Burden and Spending by Care Continuum

Lung Cancer—Unmet Needs and Opportunity Analysis

Scenario Analysis—Lung Cancer Screening Population Analysis

Overview of COPD—Disease Burden and Spending by Care Continuum

COPD—Unmet Needs and Opportunity Analysis

Scenario Analysis—COPD Medication Adherence Analysis

Overview of Cystic Fibrosis—Disease Burden and Spending by Care Continuum

Cystic Fibrosis—Unmet Needs and Opportunity Analysis

Overview of Asthma—Disease Burden and Spending by Care Continuum

Asthma—Unmet Needs and Opportunity Analysis

Scenario Analysis—Asthma Medication Adherence Analysis

Overview of Pulmonary Fibrosis—Disease Burden and Spending by Care Continuum

Pulmonary Fibrosis—Unmet Needs and Opportunity Analysis

Overview of PE—Disease Burden and Spending by Care Continuum

PE—Unmet Needs and Opportunity Analysis

Scenario Analysis—PE Medication Adherence Analysis

Overview of RTI—Disease Burden and Spending by Care Continuum

RTI—Unmet Needs and Opportunity Analysis

Overview of Chronic Bronchitis—Disease Burden and Spending by Care Continuum

Chronic Bronchitis—Unmet Needs and Opportunity Analysis

Overview of Sleep Apnea—Disease Burden and Spending by Care Continuum

Sleep Apnea—Unmet Needs and Opportunity Analysis

Scenario Analysis—Sleep Apnea Treatment Adherence Analysis

Overview of Pneumonia—Disease Burden and Spending by Care Continuum

Pneumonia—Unmet Needs and Opportunity Analysis

Overview of Pleural Effusion—Disease Burden and Spending by Care Continuum

Pleural Effusion—Unmet Needs and Opportunity Analysis

Resource and Infrastructure Analysis in the United States

Programs and Long-term Plans by Respiratory Disease Types

Programs and Long-term Plans by Respiratory Disease Types (continued)

Top-level Snapshot of Funding by Care Continuum

Top-level Snapshot of Funding by Technologies

Focus of OEMs in Sleep and Respiratory Disorders

Select List of Start-up Companies

Select List of Start-up Companies (continued)

Select List of Start-up Companies (continued)

Select List of Start-up Companies (continued)

Select List of Start-up Companies (continued)

Select List of Start-up Companies (continued)

Select List of Start-up Companies (continued)

Select List of Start-up Companies (continued)

Select List of Start-up Companies (continued)

Game Changers or Start-ups Disrupting Respiratory Industry—List of Companies

Current and Recommended Business Models

Technology 1—Respiratory Airway Clearance Vest

Technology 2—Digital Capnography (Tidal Breathing CO2) Diagnostic and Monitoring Device for Home Care

Technology 3—Smartphone-enabled or Connected Spirometers

Technology 4—Continuous Respiratory Rate Monitoring

Technology 5—Implantable Nerve Stimulator for Sleep Apnea

Technology 6—Oral Appliances for Sleep Apnea

Technology 7—Miniaturized CPAP

Technology 8—Smart Inhalers/Sensors

Technology 9—Respiratory Dialysis System (ECCO₂R Therapy)

Technology 10—Breath Analyzer for Non-invasive Lung Cancer Screening

Technology 11—AI to Process Patients’ Medical Imaging

Technology 12—Patient Management Apps

Technology 13—Wearable Devices

Technology 14—Lung Perfusion System

Technology 15—Assistive Robots

Product/Technology Pipeline in Sensor-based Technologies in Respiratory and Sleep Diseases, 2018

Analysis of M&A Deals in the Global Respiratory Device Industry

Mergers and Acquisitions

Mergers and Acquisitions (continued)

Mergers and Acquisitions (continued)

Mergers and Acquisitions (continued)

Royal Philips—M&A Strategy

Apax Medical—M&A Strategy

Key M&As Discussion

Key M&As Discussion (continued)

Key M&As Discussion (continued)

Key M&As Discussion (continued)

Select Partnerships and Collaborations in Respiratory and Sleep Disorders

Select Partnerships and Collaborations in Respiratory and Sleep Disorders (continued)

Select Partnerships and Collaborations in Respiratory and Sleep Disorders (continued)

Select Partnerships and Collaborations in Respiratory and Sleep Disorders (continued)

Select Partnerships and Collaborations in Respiratory and Sleep Disorders (continued)

Leading OEMs in Respiratory Sector Continue to Ignore Screening and Early Diagnosis

Shifting Care Delivery in Sleep and Respiratory Industry

Growth Opportunity by Technologies in the Sleep and Respiratory Industry

Select Sleep and Respiratory Technologies Impact by Care Settings

Select Sleep and Respiratory Technologies Impact by Care Settings (continued)

Growth Opportunity Areas for Companies

Growth Opportunity—Collaborations and Partnerships Among Vendors

Strategic Imperatives

Future Trends in the Sleep and Respiratory Care Industry

Growth Opportunities in Sleep and Respiratory Sector by Services/Solutions

Analyst Perspective

3 Big Predictions

Strategic Imperative and Growth Opportunities for Companies

Legal Disclaimer

List of Exhibits

List of Exhibits (continued)

List of Exhibits (continued)

List of Exhibits (continued)

List of Exhibits (continued)

The Frost & Sullivan Story

Value Proposition—Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy